Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1271027C details a solvent-free phase transfer catalysis method for dihalogenated aromatic ethers, offering high purity (>95%) and yield (>90%) for agrochemical intermediates.
Patent CN1256319C details a thionyl chloride method for L-β-asparagine. Achieves higher yields and cost reduction in pharmaceutical intermediates manufacturing.
Novel condensed-phase method for high-purity bis-phenol intermediates. Reduces costs and improves scalability for polycarbonate and polyester manufacturing.
Patent CN113881728B reveals a chemo-enzymatic route for PreQ 1, enhancing yield and reducing waste for pharmaceutical intermediate manufacturing supply chains.
Patent CN116903428B introduces CuPd catalyst for diyne synthesis offering high yield and recyclability for pharmaceutical intermediate manufacturing supply chains.
Novel enzymatic method for loxoprofen resolution offers high purity and green manufacturing advantages for pharmaceutical supply chains seeking reliable intermediate partners.
Novel copper-catalyzed route for tranylcypromine intermediates offers high ee values and cost-effective scaling for global pharmaceutical supply chains.
Patent CN102249962A reveals a room-temperature DBU-catalyzed route to 1,1-dithio-1-alkenes, eliminating expensive palladium and nickel catalysts for cost-effective manufacturing.
Patent CN102719497B details an immobilized yeast method for high-purity methyl (S)-(+)-mandelate. Offers green manufacturing and cost reduction for chiral intermediates.
Patent CN102191293A reveals a novel immobilized yeast method for high-purity duloxetine intermediates, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN1056612C details novel Salen-Mn catalysts and isoquinoline N-oxide ligands for enantioselective epoxidation, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN105017358A reveals a novel sulfonylation route for emamectin benzoate, eliminating sulfur impurities and reducing solvent swaps for cost-effective agrochemical manufacturing.
Novel biocatalytic route for nicotine intermediate using engineered imine reductase mutants offering superior conversion and stereoselectivity for industrial scale-up.
Novel Lewis acid catalyzed [5+2] cycloaddition for 1,4-diazepines. High yield, mild conditions. Reliable supplier for pharma intermediates.
Patent CN109609582A reveals microbial deracemization for L-glufosinate-ammonium. Achieve high purity and cost reduction in herbicide manufacturing with scalable biocatalysis.
Patent CN106543096A reveals a green catalytic route for naphthooxazinone derivatives, offering simplified purification and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN113801081A reveals a metal-free visible light method for 2,5-furandicarboxylic acid. Discover cost-effective, scalable bio-based monomer production strategies.
Patent CN1303077C details a rare earth-catalyzed taxane synthesis using THF, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN111138383A reveals a novel catalytic epoxidation method yielding high-purity alicyclic epoxy resin with superior color stability for electronic applications.
Patent CN117587081A reveals enzymatic synthesis for high-purity vitamin E derivatives. Discover cost-effective supply chain solutions and scalable manufacturing.